Furthermore, Bieniek et al. 27 indicated that treatment with the COX-2 inhibitors, celecoxib and CAY10404, or knockdown of COX-2 significantly inhibited prostate cancer cell proliferation. This evidence concerns the gene PTGS2 and prostate carcinoma.